Type 1 Diabetes Trial, Recruiting (NCT07240012)

Type 1 Diabetes Trial, Recruiting NCT07240012 Sponsor: Rigshospitalet, Denmark Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07240012 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

(For people who are planning a pregnancy):

Women between the ages of 18 and 45
People who have been living with type 1 diabetes for at least 12 months
People who are not currently pregnant, confirmed by a negative pregnancy test on the day they are enrolled in the trial
People who are planning to become pregnant within the next 52 weeks (about one year)

(For people who are already pregnant):

Women between the ages of 18 and 45
People who have been living with type 1 diabetes for at least 12 months
People who are pregnant with a single baby (not twins or more), confirmed by an ultrasound scan taken between 8 and 13 weeks and 6 days of pregnancy
People who agree to take part in a linked study called DDBR2 throughout the pregnancy, during delivery, and for one month after giving birth

Who may not be able to join:

People who do not have a sufficient understanding of Danish to follow spoken and written information
People with serious mental health or psychiatric conditions that the lead doctor determines would prevent safe participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +45 35458671

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07240012

Sponsor: Rigshospitalet, Denmark

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: +45 35458671

More information: https://clinicaltrials.gov/study/NCT07240012

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

(For people who are planning a pregnancy):

Women between the ages of 18 and 45
People who have been living with type 1 diabetes for at least 12 months
People who are not currently pregnant, confirmed by a negative pregnancy test on the day they are enrolled in the trial
People who are planning to become pregnant within the next 52 weeks (about one year)

(For people who are already pregnant):

Women between the ages of 18 and 45
People who have been living with type 1 diabetes for at least 12 months
People who are pregnant with a single baby (not twins or more), confirmed by an ultrasound scan taken between 8 and 13 weeks and 6 days of pregnancy
People who agree to take part in a linked study called DDBR2 throughout the pregnancy, during delivery, and for one month after giving birth

Who may not be able to join:

People who do not have a sufficient understanding of Danish to follow spoken and written information
People with serious mental health or psychiatric conditions that the lead doctor determines would prevent safe participation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Rigshospitalet, Denmark

Registry

ClinicalTrials.gov

Start date

1 December 2025

Est. completion

1 October 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Time in range; Neonatal outcome: Birthweight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov